Elite Medical Center, Al Riyadh, Saudi Arabia.
J Refract Surg. 2013 Jan;29(1):59-63. doi: 10.3928/1081597X-20121228-04.
To evaluate the safety and efficacy of intrastromal corneal ring segments (ICRS) implantation followed by same-day topography-guided photorefractive keratectomy (PRK) and ultraviolet-A/riboflavin collagen cross-linking (CXL) in patients with low to moderate keratoconus.
Patients with low to moderate keratoconus and contact lens intolerance were included in the study. All patients first underwent femtosecond laser-enabled placement of ICRS (Keraring, Mediphacos) (first step). Same-day topography-guided PRK and CXL (second step) were subsequently performed in all patients after the refraction was stable (average 6 months [range: 3 to 11 months]).
Thirteen eyes from 13 patients were included in the study. Based on values before the first step and 6 months after the second step, significant improvements were noted in uncorrected distance visual acuity (0.7±0.32 logMAR vs 0.08±0.08 logMAR), corrected distance visual acuity (CDVA) (0.16±0.19 logMAR vs 0.02±0.04 log-MAR), sphere (-3.65±3.08 diopters [D] vs 0.06±1.6 D), astigmatism (-3.31±1.5 D vs -0.98±0.75 D), average K (47.28±1.99 D vs 41.42±3.22 D), and coma (2.36±1.23 μm vs 1.47±0.68 μm) (P<.05). Approximately 63% of eyes gained ⩾2 lines of CDVA, whereas no change in CDVA was reported in ∼27% of eyes. No eyes lost lines of CDVA.
The combination of ICRS implantation followed by sequential same-day topography-guided PRK/CXL may be a reasonable option for improving visual acuity in patients with low to moderate keratoconus.
评估在中低度圆锥角膜患者中,行间质角膜环段(ICRS)植入术后即刻行 topography-guided 光折射性角膜切削术(PRK)联合紫外线-A/核黄素胶原交联(CXL)的安全性和有效性。
本研究纳入了中低度圆锥角膜且对接触镜不耐受的患者。所有患者首先接受飞秒激光辅助的 ICRS(Keraring,Mediphacos)植入(第一步)。在屈光稳定后(平均 6 个月[范围:3 至 11 个月]),所有患者均行即刻 topography-guided PRK 和 CXL(第二步)。
本研究共纳入 13 例患者的 13 只眼。根据第一步前和第二步后 6 个月的值,未矫正距离视力(0.7±0.32 logMAR 与 0.08±0.08 logMAR)、矫正距离视力(0.16±0.19 logMAR 与 0.02±0.04 logMAR)、球镜(-3.65±3.08 屈光度[D]与 0.06±1.6 D)、散光(-3.31±1.5 D 与-0.98±0.75 D)、平均 K 值(47.28±1.99 D 与 41.42±3.22 D)和彗差(2.36±1.23 μm 与 1.47±0.68 μm)均有显著改善(P<.05)。约 63%的眼获得了≥2 行的 CDVA,而约 27%的眼的 CDVA 无变化。无眼失去 CDVA。
在中低度圆锥角膜患者中,ICRS 植入后序贯行即刻 topography-guided PRK/CXL 联合治疗可能是提高视力的合理选择。